• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Characteristic miRNA expression signature and random forest survival analysis identify potential cancer-driving miRNAs in a broad range of head and neck squamous cell carcinoma subtypes.特征性miRNA表达特征及随机森林生存分析确定了多种头颈鳞状细胞癌亚型中的潜在致癌miRNA。
Rep Pract Oncol Radiother. 2018 Jan-Feb;23(1):6-20. doi: 10.1016/j.rpor.2017.10.003. Epub 2017 Nov 20.
2
Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.抗肿瘤的miR-150-5p和miR-150-3p通过靶向头颈部鳞状细胞癌中的SPOCK1抑制癌细胞的侵袭性。
Auris Nasus Larynx. 2018 Aug;45(4):854-865. doi: 10.1016/j.anl.2017.11.019. Epub 2017 Dec 9.
3
A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.微 RNA 特征面板作为预测膀胱尿路上皮癌患者生存的工具。
Dis Markers. 2018 Jun 20;2018:5468672. doi: 10.1155/2018/5468672. eCollection 2018.
4
Impact of Oncogenic Targets by Tumor-Suppressive and Regulation in Head and Neck Squamous Cell Carcinoma.抑癌基因对头颈部鳞状细胞癌中致癌靶点的调控作用。
Int J Mol Sci. 2021 Sep 14;22(18):9947. doi: 10.3390/ijms22189947.
5
Survival associated miRNA signature in patients with head and neck carcinomas.头颈部癌患者中与生存相关的微小RNA特征
Heliyon. 2023 Jun 12;9(6):e17218. doi: 10.1016/j.heliyon.2023.e17218. eCollection 2023 Jun.
6
Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.基于深度测序的头颈部鳞状细胞癌微小RNA表达特征:前体微小RNA-150双链作为抗肿瘤微小RNA
Oncotarget. 2017 May 2;8(18):30288-30304. doi: 10.18632/oncotarget.16327.
7
microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers is Mainly Dependent on HER2 Status-A Pilot Study.单激素受体阳性乳腺癌中的微小RNA表达谱主要取决于HER2状态——一项初步研究
Diagnostics (Basel). 2020 Aug 20;10(9):617. doi: 10.3390/diagnostics10090617.
8
Identification of and Target Genes: Paxillin Facilities Cancer Cell Aggressiveness in Head and Neck Squamous Cell Carcinoma.鉴定和靶基因:桩蛋白促进头颈部鳞状细胞癌的癌细胞侵袭性。
Genes (Basel). 2021 Nov 27;12(12):1910. doi: 10.3390/genes12121910.
9
Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.源自癌症基因组图谱的头颈部鳞状细胞癌预后微小RNA特征。
Cancer Med. 2016 Jul;5(7):1619-28. doi: 10.1002/cam4.718. Epub 2016 Apr 25.
10
miRNAs as Biomarkers for Diagnosing and Predicting Survival of Head and Neck Squamous Cell Carcinoma Patients.微小RNA作为诊断和预测头颈部鳞状细胞癌患者生存的生物标志物
Cancers (Basel). 2021 Aug 6;13(16):3980. doi: 10.3390/cancers13163980.

引用本文的文献

1
MiR-1293 modulates PPARGC1A to promote proliferation and metastasis of oral carcinoma cells.微小RNA-1293通过调节过氧化物酶体增殖物激活受体γ共激活因子1α促进口腔癌细胞的增殖和转移。
J Mol Histol. 2025 Jun 5;56(3):188. doi: 10.1007/s10735-025-10474-8.
2
Single-Cell RNA-Seq Recognized Key Genes for Metastasis and Macrophage Infiltration in Colorectal Cancer.单细胞RNA测序识别出结直肠癌转移和巨噬细胞浸润的关键基因。
Hum Mutat. 2025 May 15;2025:9488531. doi: 10.1155/humu/9488531. eCollection 2025.
3
The microRNA-6510 as a potential tumor suppressor in head and neck cancer.微小RNA-6510作为头颈癌中一种潜在的肿瘤抑制因子。
Sci Rep. 2025 Feb 18;15(1):5830. doi: 10.1038/s41598-025-86796-0.
4
Circulating microRNAs as a Prognostic Tool to Determine Treatment Efficacy in Lung Cancer Patients Undergoing Pembrolizumab PD-1 Blockade Immunotherapy.循环微RNA作为一种预后工具,用于判断接受帕博利珠单抗PD-1阻断免疫治疗的肺癌患者的治疗效果。
Cancers (Basel). 2024 Dec 17;16(24):4202. doi: 10.3390/cancers16244202.
5
Integrated analysis of single-cell RNA-seq and bulk RNA-seq revealed key genes for bone metastasis and chemoresistance in prostate cancer.单细胞 RNA-seq 和 bulk RNA-seq 的综合分析揭示了前列腺癌骨转移和化疗耐药的关键基因。
Genes Genomics. 2024 Dec;46(12):1445-1460. doi: 10.1007/s13258-024-01575-x. Epub 2024 Oct 12.
6
Clinical and therapeutical significances of the cluster and signature based on oxidative stress for osteosarcoma.基于氧化应激的聚类和特征在骨肉瘤中的临床和治疗意义。
Aging (Albany NY). 2023 Dec 29;15(24):15360-15381. doi: 10.18632/aging.205354.
7
Differentially Expressed Genes, miRNAs and Network Models: A Strategy to Shed Light on Molecular Interactions Driving HNSCC Tumorigenesis.差异表达基因、miRNA与网络模型:揭示驱动头颈部鳞状细胞癌发生的分子相互作用的策略
Cancers (Basel). 2023 Sep 4;15(17):4420. doi: 10.3390/cancers15174420.
8
In Silico Analysis of MicroRNA Expression Data in Liver Cancer.肝癌中微小RNA表达数据的计算机分析
Cancer Inform. 2023 May 10;22:11769351231171743. doi: 10.1177/11769351231171743. eCollection 2023.
9
Identification of neoplasm-specific signatures of miRNA interactions by employing a systems biology approach.采用系统生物学方法鉴定 miRNA 相互作用的肿瘤特异性特征。
PeerJ. 2022 Oct 3;10:e14149. doi: 10.7717/peerj.14149. eCollection 2022.
10
Immune Infiltration-Related ceRNA Network Revealing Potential Biomarkers for Prognosis of Head and Neck Squamous Cell Carcinoma.免疫浸润相关 ceRNA 网络揭示头颈部鳞状细胞癌预后的潜在生物标志物。
Dis Markers. 2022 Sep 2;2022:1014347. doi: 10.1155/2022/1014347. eCollection 2022.

本文引用的文献

1
Non-coding RNAs profiling in head and neck cancers.头颈部癌症中的非编码RNA分析
NPJ Genom Med. 2016 Jan 13;1:15004. doi: 10.1038/npjgenmed.2015.4. eCollection 2016.
2
Distinct prognostic values of alcohol dehydrogenase mRNA expression in pancreatic adenocarcinoma.酒精脱氢酶mRNA表达在胰腺腺癌中的不同预后价值。
Onco Targets Ther. 2017 Jul 24;10:3719-3732. doi: 10.2147/OTT.S140221. eCollection 2017.
3
Integrative analysis of mRNA and miRNA expression profiles in oral lichen planus: preliminary results.口腔扁平苔藓中mRNA和miRNA表达谱的综合分析:初步结果
Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Oct;124(4):390-402.e17. doi: 10.1016/j.oooo.2017.05.513. Epub 2017 Jun 8.
4
Tumor-like microenvironment in oral lichen planus: evidence of malignant transformation?口腔扁平苔藓中的肿瘤样微环境:恶变的证据?
Expert Rev Clin Immunol. 2017 Jun;13(6):635-643. doi: 10.1080/1744666X.2017.1295852. Epub 2017 Feb 28.
5
Malignant transformation of oral lichen planus and oral lichenoid lesions: A meta-analysis of 20095 patient data.口腔扁平苔藓和口腔苔藓样病变的恶性转化:对20095例患者数据的荟萃分析。
Oral Oncol. 2017 May;68:92-102. doi: 10.1016/j.oraloncology.2017.03.012. Epub 2017 Apr 5.
6
Avoiding the pitfalls of gene set enrichment analysis with SetRank.使用SetRank避免基因集富集分析的陷阱。
BMC Bioinformatics. 2017 Mar 4;18(1):151. doi: 10.1186/s12859-017-1571-6.
7
miR-503-3p promotes epithelial-mesenchymal transition in breast cancer by directly targeting SMAD2 and E-cadherin.miR-503-3p 通过直接靶向 SMAD2 和 E-钙黏蛋白促进乳腺癌中的上皮-间充质转化。
J Genet Genomics. 2017 Feb 20;44(2):75-84. doi: 10.1016/j.jgg.2016.10.005. Epub 2016 Nov 1.
8
microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.通过CRISPR/Cas9敲除微小RNA-210-3p可通过恢复肾细胞癌中TWIST1的表达促进肿瘤发生。
Oncotarget. 2017 Mar 28;8(13):20881-20894. doi: 10.18632/oncotarget.14930.
9
Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.上调的长链非编码RNA SNHG1通过抑制miR-101-3p和激活Wnt/β-连环蛋白信号通路促进非小细胞肺癌进展。
Oncotarget. 2017 Mar 14;8(11):17785-17794. doi: 10.18632/oncotarget.14854.
10
A single nucleotide variant in microRNA-1269a promotes the occurrence and process of hepatocellular carcinoma by targeting to oncogenes SPATS2L and LRP6.微小RNA-1269a中的一个单核苷酸变体通过靶向癌基因SPATS2L和LRP6促进肝细胞癌的发生和发展。
Bull Cancer. 2017 Apr;104(4):311-320. doi: 10.1016/j.bulcan.2016.11.021. Epub 2017 Jan 9.

特征性miRNA表达特征及随机森林生存分析确定了多种头颈鳞状细胞癌亚型中的潜在致癌miRNA。

Characteristic miRNA expression signature and random forest survival analysis identify potential cancer-driving miRNAs in a broad range of head and neck squamous cell carcinoma subtypes.

作者信息

Nunez Lopez Yury O, Victoria Berta, Golusinski Pawel, Golusinski Wojciech, Masternak Michal M

机构信息

Translational Research Institute for Metabolism & Diabetes, Florida Hospital, 301 East Princeton St., Orlando, FL 32804, USA.

Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, 6900 Lake Nona Blvd., Orlando, FL 32827, USA.

出版信息

Rep Pract Oncol Radiother. 2018 Jan-Feb;23(1):6-20. doi: 10.1016/j.rpor.2017.10.003. Epub 2017 Nov 20.

DOI:10.1016/j.rpor.2017.10.003
PMID:29187807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5698002/
Abstract

AIM

To characterize the miRNA expression profile in head and neck squamous cell carcinoma (HNSSC) accounting for a broad range of cancer subtypes and consequently identify an optimal miRNA signature with prognostic value.

BACKGROUND

HNSCC is consistently among the most common cancers worldwide. Its mortality rate is about 50% because of the characteristic aggressive behavior of these cancers and the prevalent late diagnosis. The heterogeneity of the disease has hampered the development of robust prognostic tools with broad clinical utility.

MATERIALS AND METHODS

The Cancer Genome Atlas HNSC dataset was used to analyze level 3 miRNA-Seq data from 497 HNSCC patients. Differential expression (DE) analysis was implemented using the package and multivariate linear model that adjusted for the confounding effects of age at diagnosis, gender, race, alcohol history, anatomic neoplasm subdivision, pathologic stage, T and N stages, and vital status. Random forest (RF) for survival analysis was implemented using the package.

RESULTS

A characteristic DE miRNA signature of HNSCC, comprised of 11 upregulated (i.e., miR-196b-5p, miR-1269a, miR-196a-5p, miR-4652-3p, miR-210-3p, miR-1293, miR-615-3p, miR-503-5p, miR-455-3p, miR-205-5p, and miR-21-5p) and 9 downregulated (miR-376c-3p, miR-378c, miR-29c-3p, miR-101-3p, miR-195-5p, miR-299-5p, miR-139-5p, miR-6510-3p, miR-375) miRNAs was identified. An optimal RF survival model was built from seven variables including age at diagnosis, miR-378c, miR-6510-3p, stage N, pathologic stage, gender, and race (listed in order of variable importance).

CONCLUSIONS

The joint differential miRNA expression and survival analysis controlling for multiple confounding covariates implemented in this study allowed for the identification of a previously undetected prognostic miRNA signature characteristic of a broad range of HNSCC.

摘要

目的

描述涵盖广泛癌症亚型的头颈部鳞状细胞癌(HNSSC)中的微小RNA(miRNA)表达谱,从而确定具有预后价值的最佳miRNA特征。

背景

头颈部鳞状细胞癌一直是全球最常见的癌症之一。由于这些癌症具有侵袭性特征且普遍诊断较晚,其死亡率约为50%。该疾病的异质性阻碍了具有广泛临床应用价值的可靠预后工具的开发。

材料与方法

使用癌症基因组图谱头颈部鳞状细胞癌数据集分析来自497名头颈部鳞状细胞癌患者的3级miRNA测序数据。使用该软件包和多变量线性模型进行差异表达(DE)分析,该模型针对诊断时年龄、性别、种族、饮酒史、肿瘤解剖细分、病理分期、T和N分期以及生存状态的混杂效应进行了调整。使用该软件包进行随机森林(RF)生存分析。

结果

确定了头颈部鳞状细胞癌的一个特征性DE miRNA特征,由11个上调(即miR-196b-5p、miR-1269a、miR-196a-5p、miR-4652-3p、miR-210-3p、miR-1293、miR-615-3p、miR-503-5p、miR-455-3p、miR-205-5p和miR-21-5p)和9个下调(miR-376c-3p、miR-378c、miR-29c-3p、miR-101-3p、miR-195-5p、miR-299-5p、miR-139-5p、miR-6510-3p、miR-375)的miRNA组成。从包括诊断时年龄、miR-378c、miR-6510-3p、N分期、病理分期、性别和种族(按变量重要性顺序列出)的七个变量构建了一个最佳RF生存模型。

结论

本研究中实施的联合差异miRNA表达和生存分析,同时控制了多个混杂协变量,从而能够识别出一种先前未被发现的、广泛的头颈部鳞状细胞癌特征性预后miRNA特征。